← Back to news
Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL - CancerNetwork

Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL - CancerNetwork

Published: June 14, 2026 · Google News

View original

Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL  CancerNetwork